Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study).
- DOI
- 10.1177/03331024251398011
- Published
- 2025 Dec
- Container
- Cephalalgia : an international journal of headache
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/03331024251398011,
title = {Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study).},
author = {Iannone LF and Romozzi M and Russo A and Finkelstein I and Seabi D and Ahlden A and Aamodt AH and Caronna E and Pozo-Rosich P and Tronvik EA and Sundal C},
year = {2025},
journal = {Cephalalgia : an international journal of headache},
doi = {10.1177/03331024251398011},
url = {https://doi.org/10.1177/03331024251398011}
}RIS
TY - JOUR TI - Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study). AU - Iannone LF AU - Romozzi M AU - Russo A AU - Finkelstein I AU - Seabi D AU - Ahlden A AU - Aamodt AH AU - Caronna E AU - Pozo-Rosich P AU - Tronvik EA AU - Sundal C PY - 2025 JO - Cephalalgia : an international journal of headache DO - 10.1177/03331024251398011 UR - https://doi.org/10.1177/03331024251398011 ER -
APA
LF, I., M, R., A, R., I, F., D, S., A, A., AH, A., E, C., P, P., EA, T., & C, S. (2025). Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study).. Cephalalgia : an international journal of headache. https://doi.org/10.1177/03331024251398011
Source records
- pubmed · retrieved 2026-09-25T11:50:56.392Z